NOVOLOG 100 [iU]/mL
insulin aspart · INJECTION, SOLUTION · Novo Nordisk
No Recall HistoryCurrently in Shortage
Plain English
NOVOLOG is a injection, solution containing insulin aspart at 100 [iU]/mL, taken intravenous. Manufactured by Novo Nordisk.
Key Facts
- Brand Name
- NOVOLOG
- Generic Name
- insulin aspart
- NDC Code (Product)
0169-6338- Manufacturer
- Novo Nordisk
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA020986
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 10/31/2013
Recall History
No Recall HistoryFrequently Asked Questions
What is NOVOLOG used for?
NOVOLOG contains insulin aspart. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is NOVOLOG a controlled substance?
NOVOLOG is not classified as a controlled substance by the DEA.
What is the generic name for NOVOLOG?
The generic name for NOVOLOG is insulin aspart. There are 11 other brand versions of insulin aspart.
What is the NDC code for NOVOLOG 100 [iU]/mL?
The NDC (National Drug Code) for NOVOLOG 100 [iU]/mL is 0169-6338, listed by Novo Nordisk.
Product NDC
0169-6338
Other NOVOLOG Dosages
Other Insulin Brands
See all →- KIRSTY100 [iU]/mL83257-007
- Insulin Aspart Protamine and Insulin Aspart Mix 70/30100 [iU]/mL70518-3236
- KIRSTY100 [iU]/mL83257-008
- NovoLog Mix 70/30100 [iU]/mL0169-3696
- NovoLog Mix 70/30100 [iU]/mL0169-3685
- Insulin Aspart100 [iU]/mL50090-4956
- MERILOG100 [iU]/mL0024-5927
- NovoLog Mix 70/30100 [iU]/mL70518-2119
- Insulin Aspart100 [iU]/mL73070-102
- Fiasp100 [iU]/mL0169-3201
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)